Navigation Links
New Scrip Report Provides Strategic Insight on the Burgeoning Biosimilars Market
Date:10/3/2007

LONDON, October 3 /PRNewswire/ -- Every successful originator company will one day be involved in or competing with biosimilar products, making biosimilars development a critical part of the future of biotechnology, says a new Scrip Report.

The first generation of biopharmaceuticals manufactured using recombinant technologies was launched in the 1980s, and patents protecting them are now nearing expiration. As with small molecule drugs, the expiration of patents creates an opportunity for generic biologicals to enter the market. This means that competition from biosimilars is likely to be a challenge for every successful biopharmaceutical product.

'Biosimilars, Biogenerics and Follow-on Biologics', a 237-page report, provides an in-depth review of the various milestones that have led the biosimilars arena to where it is today, as well as strategic insight for companies in both camps: the firms that are investing their R&D efforts into developing new biosimilars, and the innovators that are looking for ways to counter this new challenge. And the challenge is a significant one: from sales of $30 million in 2006, the biosimilars market is expected to be worth $3.2 billion as soon as 2011.

The EU already has legislation in place for the approval of biosimilars and, according to the Report, is expected to lead the way in the evolution of the biosimilars sector, making up 45% of the world market. The situation in the US has been more hotly contested, but this crucial market is set to follow Europe's lead following the passing of landmark legislation by the US Senate Health Committee in June 2007. In the same month another significant milestone in the development of biosimilars was reached when the European medicines agency (EMEA) recommended three biosimilar versions of recombinant erythropoietin (EPO), a complex glycoprotein, for approval.

The Report describes how companies are currently targeting products that are off-patent in Europe: in
'/>"/>

SOURCE Scrip Reports
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
2. Omniscript RT Kit
3. Suggested applications for reverse transcriptases
4. Properties of Reverse Transcriptases
5. Reverse transcriptases suitable for one-step RT-PCRb
6. Reverse transcriptases suitable for two-step RT-PCRd
7. C. therm. Polymerase for Reverse Transcription in Two-Step RT-PCR
8. Choice of reverse transcription primers
9. Transcriptor Reverse Transcriptase
10. Increase the Power and Sensitivity for Your cDNA Synthesis with the New Transcriptor Reverse Transcriptase
11. Use of Transcriptor Reverse Transcriptase in Microarray Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... IRVINE, Calif. (PRWEB) August 19, 2014 ... Indiegogo campaign to raise $200,000 to fund a ... diagnostic device. , This development is a ... one-size-fits-all model of care to the implementation of ... patient-centric method of practicing medicine. , Indiegogo contributions ...
(Date:8/19/2014)... 2014 Robin Williams’ passing is a ... on an individual. Symptoms range from slowness of ... swallowing and severe depression. Parkinson’s disease progressively gets ... dopamine producing neurons of the brain. As these ... slowly and progressively gets worse, they look for options. ...
(Date:8/19/2014)... Research and Markets ... "Spectroscopy Equipment and Accessories - Global Strategic ... This report analyzes the ... in US$ Thousands by the following Product ... NMR-EPR Spectrometers, Near Infrared (NIR) Spectrometers, IR ...
(Date:8/19/2014)... In November 2012, the European Union (EU) mandated use of ... new PSUR – responding to the increasing need to understand ... Adopted in many regions, the main objectives of the PBRER ... critical analysis of new or emerging information on the risks ... of the potential benefits of a drug; and , ...
Breaking Biology Technology:Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2
... of conventional and current solar cells include high production ... rely on toxic and scarce materials. Northwestern University researchers ... will minimize all of these solar energy technology limitations. ... solve the problem of the Grtzel cell, a promising ...
... JOSE, Calif., May 23, 2012  Ariosa Diagnostics, a molecular ... that provides more information on the factors which may ... blood. The study was led by Professor Kypros Nicolaides, ... at King,s College Hospital in the United Kingdom. ...
... May 23, 2012 Reportlinker.com announces that ... in its catalogue: ... Nanocrystals http://www.reportlinker.com/p0799333/Nanotechnology-for-Drug-Delivery-Global-Market-for-Nanocrystals.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... a $136 billion nanotechnology-enabled drug delivery market ...
Cached Biology Technology:Taking solar technology up a notch 2Taking solar technology up a notch 3Ariosa Diagnostics Announces Publication of Study on Influential Factors Affecting Fetal DNA Concentration in Blood of Pregnant Women 2Nanotechnology for Drug Delivery: Global Market for Nanocrystals 2Nanotechnology for Drug Delivery: Global Market for Nanocrystals 3Nanotechnology for Drug Delivery: Global Market for Nanocrystals 4Nanotechnology for Drug Delivery: Global Market for Nanocrystals 5Nanotechnology for Drug Delivery: Global Market for Nanocrystals 6Nanotechnology for Drug Delivery: Global Market for Nanocrystals 7Nanotechnology for Drug Delivery: Global Market for Nanocrystals 8Nanotechnology for Drug Delivery: Global Market for Nanocrystals 9
(Date:8/20/2014)... Arizona State University, the Wellcome Trust Sanger Institute and ... isolated Mycobacterium pinnipedii from skeletons found in ... pathogen is a relative of the TB bacterium that ... today. These researchers assume that seals carried the pathogens ... sea lions was unexpected" comments Sebastien Gagneux, from the ...
(Date:8/20/2014)... Institutes of Health has awarded the Oklahoma Medical Research ... research on anthrax and the bacteria,s effects on humans. ... Ph.D., and his colleagues have studied the human immune ... Centers for Human Immunology. The original funding came soon ... the heels of the terrorist attacks of Sept. 11, ...
(Date:8/20/2014)... spiciness that is irresistible to some, but intolerable to ... their findings to develop a new drug candidate for ... inflammation or other problems. They reported their progress on ... in ACS, Journal of Medicinal Chemistry . , ... had pegged a compound called capsaicin as the active ...
Breaking Biology News(10 mins):$14.5 million grant awarded to continue anthrax studies 2
... the waters off the North Carolina coast, historically-significant World ... a testament to a relatively unknown chapter in U.S. ... are not only important for their cultural value, but ... invertebrates and algal species. Additionally, due to their unique ...
... 24, 2011 A team of scientists from The ... to kill the deadliest antibiotic-resistant bacteria. The compound could ... life-threatening and highly resistant bacterial infections. The results ... Journal of the American Chemical Society . ...
... AURORA, Colo. (Aug. 24, 2011) A scientist investigating ... motor coordination has found that key eye reflexes are substantially ... Medicine researcher Alberto Costa, MD, Ph.D., could lead to new ... aimed at improving quality of life for those with this ...
Cached Biology News:Scientists reengineer antibiotic to overcome dangerous antibiotic-resistant bacteria 2Scientists reengineer antibiotic to overcome dangerous antibiotic-resistant bacteria 3Scientists reengineer antibiotic to overcome dangerous antibiotic-resistant bacteria 4Researcher finds altered cerebella in those with Down syndrome 2
... Ciphergen's ProteinChip arrays have been ... from biological samples. A variety of ... of proteins according to their unique ... different spots, allowing side-by-side sample comparison, ...
Freeze 'N Squeeze DNA gel extraction spin columns use a quick freeze-and-thaw cycle and centrifugation to draw 50-23,000 bp DNA out of agarose gel slices. Supplied as 25 columns....
The Freeze 'N Squeeze DNA gel extraction kit uses a quick freeze-and-thaw cycle and centrifugation to draw 50-23,000 bp DNA out of agarose gel slices. The kit includes materials for 100 preps....
The Sony UPD895 printer is used to print data captured with the Gel Doc XR and ChemiDoc XRS gel documentation systems as well as the VersaDoc imaging systems....
Biology Products: